- Home
- CEVA vs SANA Comparison
CEVA vs SANA Comparison
Compare CEVA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEVA
- SANA
- Stock Information
- Founded
- CEVA 1999
- SANA 2018
- Country
- CEVA United States
- SANA United States
- Employees
- CEVA N/A
- SANA N/A
- Industry
- CEVA Semiconductors
- SANA Medicinal Chemicals and Botanical Products
- Sector
- CEVA Technology
- SANA Health Care
- Exchange
- CEVA Nasdaq
- SANA Nasdaq
- Market Cap
- CEVA 558.8M
- SANA 519.8M
- IPO Year
- CEVA 2000
- SANA 2021
- Fundamental
- Price
- CEVA $22.97
- SANA $1.65
- Analyst Decision
- CEVA Strong Buy
- SANA Strong Buy
- Analyst Count
- CEVA 5
- SANA 5
- Target Price
- CEVA $38.60
- SANA $9.50
- AVG Volume (30 Days)
- CEVA 258.1K
- SANA 4.4M
- Earning Date
- CEVA 05-07-2025
- SANA 05-07-2025
- Dividend Yield
- CEVA N/A
- SANA N/A
- EPS Growth
- CEVA N/A
- SANA N/A
- EPS
- CEVA N/A
- SANA N/A
- Revenue
- CEVA $106,939,000.00
- SANA N/A
- Revenue This Year
- CEVA $11.13
- SANA N/A
- Revenue Next Year
- CEVA $13.14
- SANA N/A
- P/E Ratio
- CEVA N/A
- SANA N/A
- Revenue Growth
- CEVA 9.77
- SANA N/A
- 52 Week Low
- CEVA $16.02
- SANA $1.26
- 52 Week High
- CEVA $38.94
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- CEVA 39.14
- SANA 42.97
- Support Level
- CEVA $21.95
- SANA $1.53
- Resistance Level
- CEVA $24.10
- SANA $1.92
- Average True Range (ATR)
- CEVA 1.77
- SANA 0.22
- MACD
- CEVA 0.17
- SANA 0.05
- Stochastic Oscillator
- CEVA 49.73
- SANA 59.09
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.